Search research articles
Contact Us
Filters
Showing results (121-130 of 155) with videos related to
Page
of 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 26, 2026
Neoadjuvant Durvalumab ± Tremelimumab in Combination With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Carcinoma: Results of the Phase I/II NEMIO Study
Constance Thibault, Mostefa Bennamoun, Aude Fléchon, et al.
BMJ Oncology
|
January 31, 2025
Predictive biomarkers and specific immune responses of COVID-19 mRNA vaccine in patients with cancer: prospective results from the CACOV-VAC trial
Laurie Spehner, Emeline Orillard, Antoine Falcoz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 4, 2025
Combined Analyses of Circulating Tumor DNA and Immunoscore in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France/HORG-IDEA-Greece Trials
Julien Taieb, John Souglakos, Ioannis Boukovinas, et al.
The Lancet. Oncology
|
October 18, 2015
Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial
Christophe Tournigand, Benoist Chibaudel, Benoit Samson, et al.
Cancer Medicine
|
June 3, 2016
Prognostic value of health-related quality of life for death risk stratification in patients with unresectable glioblastoma
Brice Paquette, Dewi Vernerey, Bruno Chauffert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 4, 2025
Neoadjuvant FOLF(IRIN)OX Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Multicenter Randomized Noncomparative Phase II Trial (PANACHE01 FRENCH08 PRODIGE48 study)
Lilian Schwarz, Jean-Baptiste Bachet, Aurelia Meurisse, et al.
Cancers
|
July 20, 2019
<i>BRAF</i> Mutation Status in Circulating Tumor DNA from Patients with Metastatic Colorectal Cancer: Extended Mutation Analysis from the AGEO RASANC Study
Leo Mas, Jean-Baptiste Bachet, Valerie Taly, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 8, 2024
Management of biliary tract cancers in early-onset patients: A nested multicenter retrospective study of the ACABI GERCOR PRONOBIL cohort
Antoine Lebeaud, Leony Antoun, Jane-Rose Paccard, et al.
British Journal of Cancer
|
May 14, 2024
Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases
Thomas Aparicio, Julie Henriques, Magali Svrcek, et al.
Experimental Hematology & Oncology
|
July 21, 2023
DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: a multicenter propensity score-matching study
Stefano Kim, Véronique Vendrely, Angélique Saint, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 155) with videos related to
Sort By:
Page
of 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 26, 2026
Neoadjuvant Durvalumab ± Tremelimumab in Combination With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Carcinoma: Results of the Phase I/II NEMIO Study
Constance Thibault, Mostefa Bennamoun, Aude Fléchon, et al.
BMJ Oncology
|
January 31, 2025
Predictive biomarkers and specific immune responses of COVID-19 mRNA vaccine in patients with cancer: prospective results from the CACOV-VAC trial
Laurie Spehner, Emeline Orillard, Antoine Falcoz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 4, 2025
Combined Analyses of Circulating Tumor DNA and Immunoscore in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France/HORG-IDEA-Greece Trials
Julien Taieb, John Souglakos, Ioannis Boukovinas, et al.
The Lancet. Oncology
|
October 18, 2015
Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial
Christophe Tournigand, Benoist Chibaudel, Benoit Samson, et al.
Cancer Medicine
|
June 3, 2016
Prognostic value of health-related quality of life for death risk stratification in patients with unresectable glioblastoma
Brice Paquette, Dewi Vernerey, Bruno Chauffert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 4, 2025
Neoadjuvant FOLF(IRIN)OX Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Multicenter Randomized Noncomparative Phase II Trial (PANACHE01 FRENCH08 PRODIGE48 study)
Lilian Schwarz, Jean-Baptiste Bachet, Aurelia Meurisse, et al.
Cancers
|
July 20, 2019
<i>BRAF</i> Mutation Status in Circulating Tumor DNA from Patients with Metastatic Colorectal Cancer: Extended Mutation Analysis from the AGEO RASANC Study
Leo Mas, Jean-Baptiste Bachet, Valerie Taly, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 8, 2024
Management of biliary tract cancers in early-onset patients: A nested multicenter retrospective study of the ACABI GERCOR PRONOBIL cohort
Antoine Lebeaud, Leony Antoun, Jane-Rose Paccard, et al.
British Journal of Cancer
|
May 14, 2024
Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases
Thomas Aparicio, Julie Henriques, Magali Svrcek, et al.
Experimental Hematology & Oncology
|
July 21, 2023
DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: a multicenter propensity score-matching study
Stefano Kim, Véronique Vendrely, Angélique Saint, et al.
Page
of 16